|
1
|
Ando H, Kondoh H, Ichihashi M and Hearing
VJ: Approaches to identify inhibitors of melanin biosynthesis via
the quality control of tyrosinase. J Invest Dermatol. 127:751–761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang N and Hebert DN: Tyrosinase
maturation through the mammalian secretory pathway: bringing color
to life. Pigment Cell Res. 19:3–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Uong A and Zon LI: Melanocytes in
development and cancer. J Cell Physiol. 222:38–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kushimoto T, Basrur V, Valencia J,
Matsunaga J, Vieira WD, Ferrans VJ, Muller J, Appella E and Hearing
VJ: A model for melanosome biogenesis based on the purification and
analysis of early melanosomes. Proc Natl Acad Sci USA.
98:10698–10703. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watabe H, Valencia JC, Le Pape E,
Yamaguchi Y, Nakamura M, Rouzaud F, Hoashi T, Kawa Y, Mizoguchi M
and Hearing VJ: Involvement of dynein and spectrin with early
melanosome transport and melanosomal protein trafficking. J Invest
Dermatol. 128:162–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Godbole D, Mojamdar M and Pal JK:
Increased level of p27 subunit of proteasomes and its
co-localization with tyrosinase in amelanotic melanoma cells
indicate its direct role in the regulation of melanin biosynthesis.
Cell Biol Int. 30:895–902. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohashi A, Funasaka Y, Ueda M and Ichihashi
M: c-KIT receptor expression in cutaneous malignant melanoma and
benign melanotic naevi. Melanoma Res. 6:25–30. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohshima Y, Yajima I, Takeda K, Iida M,
Kumasaka M, Matsumoto Y and Kato M: c-RET molecule in malignant
melanoma from oncogenic RET-carrying transgenic mice and human cell
lines. PLoS One. 5:e102792010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peebles PT, Trisch T and Papageorge AG:
Isolation of four unusual pediatric solid tumor cell lines. Pediat
Res. 12:4851978. View Article : Google Scholar
|
|
10
|
Katagata Y and Hirayama T: Unexpected
expression of Hsp47, a replacement of one amino acid (Val 7 Leu) in
the amino terminal region, in cultured human tumorigenic cell
lines. J Dermatol Sci. 49:33–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ando H, Funasaka Y, Oka M, Ohashi A,
Furumura M, Matsunaga J, Matsunaga N, Hearing VJ and Ichihashi M:
Possible involvement of proteolytic degradation of tyrosinase in
the regulatory effect of fatty acids on melanogenesis. J Lipid Res.
40:1312–1316. 1999.PubMed/NCBI
|
|
12
|
Branza-Nichita N, Negroiu G, Petrescu AJ,
Garman EF, Platt FM, Wormald MR, Dwek RA and Petrescu SM: Mutations
at critical N-glycosylation sites reduce tyrosinase activity by
altering folding and quality control. J Biol Chem. 275:8169–8175.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asryants RA, Duszenkova IV and Nagradova
NK: Determination of Sepharose-bound protein with Coomassie
brilliant blue G-250. Anal Biochem. 151:571–574. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi H, Ahn S, Chang H, Cho NS, Joo K, Lee
BG, Chang I and Hwang JS: Influence of N-glycan processing
disruption on tyrosinase and melanin synthesis in HM3KO melanoma
cells. Exp Dermatol. 16:110–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ibarrola-Villava M, Hu HH, Guedj M,
Fernandez LP, Descamps V, Basset-Seguin N, Bagot M, Benssussan A,
Saiag P, Fargnoli MC, et al: MC1R, SLC45A2 and TYR genetic variants
involved in melanoma susceptibility in southern European
populations: results from a meta-analysis. Eur J Cancer.
48:2183–2191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chien V, Aitken JF, Zhang S, Buchanan CM,
Hickey A, Brittain T, Cooper GJ and Loomes KM: The chaperone
proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and
formation of β-sheet-containing aggregates by human amylin: a
potential role for defective chaperone biology in Type 2 diabetes.
Biochem J. 432:113–121. 2010.PubMed/NCBI
|
|
17
|
Mikami K, Yamaguchi D, Tateno H, Hu D, Qin
SY, Kawasaki N, Yamada M, Matsumoto N, Hirabayashi J, Ito Y and
Yamamoto K: The sugar-binding ability of human OS-9 and its
involvement in ER-associated degradation. Glycobiology. 20:310–321.
2010. View Article : Google Scholar : PubMed/NCBI
|
